Skip to main content
. 2013 Apr;87(8):4772–4777. doi: 10.1128/JVI.03122-12

Table 1.

HCV epitope sequence during early acute and during chronic HCV infections

Chimpanzee (infection outcome) Epitope locationa Wk after infectionb Amino acid sequencec No. of clones with indicated sequence/no. of clones sequenced
Ch6461 (self limited) NS31278–1285 0 GVDPNIRTGVRTITTGSP
8* ------------------ 17/17
NS5A2290–2298 0 LPVWARPDYNPPLVETWKK
8* ------------------- 22/24
-----Q------------- 1/24
----------L-------- 1/24
Ch6455 (self limited) NS31359–1367 0 SVTVSHPNIEEVALSTTGE
8* ------------------- 16/18
--I---------------- 1/18
------------------R 1/18
Ch6411 (chronic) E2588–596 0 TDCFRKHPEATYSRCGSGP
9* ------------------- 22/23
-------L----------- 1/23
26 ------------------- 7/21
---------T--------- 11/21
----------L-------- 1/21
----------S-------- 1/21
-----T---T--------- 1/21
Ch6412 (chronic) NS31359–1367 0 SVTVSHPNIEEVALSTTGE
11* ------------------- 24/24
26 ----P-------------- 23/23
a

NS31278 and NS5A2290 are Patr-B*0301/02 restricted, NS31359 is Patr-B*1301 restricted, and E2588 is Patr-A*0401 restricted.

b

The HCV sequence that is indicated for the week 0 time point is the sequence of the HCV inoculum. *, first time point at which tetramer+ CD8 T cells were detected in the blood.

c

The epitope sequence is in boldface and underlined. Hyphens indicate amino acids identical to those at inoculation.